Position in GILD
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$2,313,664
-$200,988 QoQ
Shares Held
18,313
+1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.40%
of 13F equity value
Holder Rank
#791
of 2,266 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Core Wealth Partners LLC holds $9,914,904 across 8 Drug Manufacturers - General names. GILD ranks #2 (23.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
11,580 | $2,940,972 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
18,313 | $2,313,664 | |
| 3 | ABBV |
AbbVie Inc.
|
6,948 | $1,748,394 | |
| 4 | LLY |
ELI LILLY & Co
|
1,132 | $1,357,754 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,447 | $828,439 | |
| 6 | PFE |
Pfizer Inc
|
11,587 | $279,014 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,220 | $243,156 | |
| 8 | AMGN |
Amgen Inc
|
562 | $203,511 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,313,664 | 18,313 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $2,514,652 | 18,043 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,331,814 | 18,998 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,089,131 | 18,821 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,075,597 | 18,721 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,070,571 | 18,479 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,692,495 | 18,323 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,522,869 | 18,164 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,246,232 | 18,164 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||